Therapy Name | S-equol |
Therapy Description |
S-equol is a plant-derived estrogen receptor agonist, which may decrease tumor cell growth (PMID: 21790611, PMID: 24487643). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
S-equol | S-equol is a plant-derived estrogen receptor agonist, which may decrease tumor cell growth (PMID: 21790611, PMID: 24487643). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status |
---|---|---|---|---|
NCT02352025 | Phase I | S-equol | S-equol in Women With Triple Negative Breast Cancer | Recruiting |